US · USD
BBIO
BridgeBio Pharma Inc
- Day's range
- $66.66 – $68.00
- Day's volume
- $13M
- 52-week range
- $53.24 – $90.17
Follow BBIO in the Fuolio
See how BBIO weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountBBIO in numbers
- Market cap
- $13B
- P/B
- -5.15
- Dividend yield (12m)
- 0.00%
BBIO price history
BBIO risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | -7.95% | +130.88% | +63.67% |
| Volatility (annualized) | 30.81% | 44.47% | 77.81% |
| Largest drawdown | -17.84% | -42.01% | -83.14% |
| Positive months | 6/12 | 21/36 | 31/60 |
How much did investing in BBIO return?
$1,000.00 invested on 11/01/2021 would be worth $1,636.67 today.
- Value today in BBIO
- $1,636.67
- Return over the period
- +63.67%
- Return per year
- +10.51%
- In the S&P 500
- $1,713.96
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
BBIO fundamentals
Valuation
- P/E—
- P/B-5.15
- EV/EBITDA-30.48
- EV/EBIT-30.16
- EV/Revenue21.06
- P/EBIT-26.20
- P/S18.29
- P/OCF-30.02
- P/FCF-29.95
- Earnings yield-3.32%
- PEG ratio—
- Earnings per share—
- Book value per share-$12.87
Debt
- Net debt$2B
- Net debt/EBITDA—
- Net debt/Equity-0.79
- Debt/Equity-1.05
- Current ratio1.23
- Quick ratio1.17
- Cash ratio0.76
Efficiency
- Gross margin94.44%
- EBITDA margin-69.10%
- Operating margin-69.81%
- Net margin—
- Asset turnover0.59
Growth
- Revenue CAGR (5 years)62.60%
- Earnings CAGR (5 years)—
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
BBIO's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| P/B | -7.11 | -3.56 | -5.24 | -0.92 | -2.83 | 182.92 | 10.62 |
| Book value per share | -$10.76 | -$7.72 | -$7.70 | -$8.29 | -$5.90 | $0.39 | $3.30 |
| Gross margin | 95.82% | 98.25% | 73.71% | 95.58% | 96.08% | — | — |
| EBITDA margin | -103.17% | -264.49% | -6,458.95% | -650.93% | -818.73% | -5,734.34% | -654.29% |
BBIO's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $502.1M | $221.9M | $9.3M | $77.6M | $69.7M | $8.2M |
| Cost of revenue | -$21M | -$3.9M | -$2.4M | -$3.4M | -$2.7M | — |
| Gross profit | $481.1M | $218M | $6.9M | $74.2M | $67M | — |
| EBITDA | -$518M | -$586.9M | -$600.9M | -$505.4M | -$570.8M | -$473M |
| EBIT | -$523.4M | -$593M | -$607.4M | -$512.2M | -$576.6M | -$474.5M |
| Financial result | -$209.1M | $50.8M | -$45.9M | $27.6M | -$9.8M | -$31M |
| Income before tax | -$732.5M | -$542.2M | -$653.3M | -$484.7M | — | $505.5M |
| Income tax | -$435K | -$1.2M | -$0 | -$0 | — | — |
| Net income | — | — | — | — | — | — |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does BBIO pay dividends?
BBIO has no distributions on record.
About Bridgebio Pharma
- Sector
- Manufacturing
Questions about BBIO
How much is BBIO today?
BBIO is at $66.29 (0.22% on the day), last traded on 10/06/2026.
How much did BBIO return in 12 months?
BBIO returned -7.95% in 12 months, with annualized volatility of 30.81% and a largest drawdown of -17.84%.